SCR-LIP-000285 · Claim · machine-readable JSON →
A systematic review reported that lipedema is poorly recognized clinically—only 46.2% of 251 Vascular Society of Great Britain and Ireland consultants recognized it (Tiwari 2006)—and that it was absent from MeSH/EMBASE and ICD-WHO as of 2012, while non-contrast CT showed 95% sensitivity and 100% specificity and the spared foot dorsum (negative Stemmer sign) helps distinguish lipedema from lymphedema.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 1 source(s)
- Answers
- 3 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Lipedema: an overview of its clinical manifestations, diagnosis and treatment of the disproportional fatty deposition syndrome – systematic review — Forner‐Cordero et al. (2012) ✓ verified — consistent · review · 2012 · reading confidence: high
“apenas 46,2% dos 251 consultores do Vascular Society of Great Britain and Ireland reconheciam lipedema em levantamento (Tiwari 2006)”
The review explicitly documents widespread under-recognition of lipedema (low clinician recognition rate, absence from coding systems, 'hidden epidemic') and describes diagnostic criteria and imaging tools (clinical staging, CT sensitivity/
Context (PECO)
Answers these questions
- Is lipedema underdiagnosed, and can screening tools help identify it? consistent
- Is lipedema underdiagnosed, misdiagnosed, or diagnosed late? consistent
- Can screening tools or questionnaires help identify lipedema cases? consistent
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000004